An observational study in Shoulder Injuries, Knee Injuries and Hip Injuries, sponsored by Stryker Endoscopy. Recruiting at 3 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-05-29.
Sponsored by Stryker Endoscopy (part of Stryker) · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 39 studies in Shoulder Injuries with a site in United States — 14 open to participants now, 18 under way, none of them phase 3. Shoulder Injuries · United States.
Among the 39 studies in Shoulder Injuries with a site in United States, this one has the largest planned enrollment of the 13 observational ones that give a count, is one of 6 that started in 2023, is one of 13 observational ones, reaches primary completion later than 3 of the 17 other live ones, and was the 33rd registered.
118 studies on the registry are indexed under Shoulder Injuries; 32 are open to participants now.
Browse Shoulder Injuries studies →14 of the 39 studies in Shoulder Injuries with a site in United States are open now. Recruiting first, the newest first:
Cedars-Sinai Medical Center · Sites in United States
Ages 18+
Stanford University · Sites in United States
Ages 18+
University of Maryland, Baltimore · Sites in United States
Ages 18–95 · Healthy volunteers
Duke University · Sites in United States
Ages 18–80
Zimmer Biomet · Sites in United States, Japan, New Zealand
Ages 20+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 17 Shoulder Injuries studies recruiting now, 8 (47%) set no upper age limit and 6 (35%) stop at 75 or younger; none take children under 18; 4 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
39 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 6 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 1,500 is above the median of 60 across 45 observational studies indexed under Shoulder Injuries.
Median enrollment 64 across the 26 interventional studies, 59 across the 13 observational. Of the 20 that completed or were terminated, 5 (25%) have results posted.
This tab as a report to print or save as PDF → With an account.
10 of 39 have an industry lead sponsor. The 10 most frequent:
This study is registered under Stryker Endoscopy, one of the names counted as Stryker. Under that name alone:
Stryker Endoscopy is the lead sponsor of 4 studies on the registry; 3 are open to participants now.
Stryker has 1 study filed under Shoulder Injuries — fewer than ten, so there is no comparison to draw.
7 of the studies in Shoulder Injuries with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06016257Cedars-Sinai Medical CenterUsing VirtuaCareTM Platform for Home Programs in Acute and Chronic Shoulder Conditions: A Pilot Study | 2026-12-31 |
| NCT04109638Stanford UniversityPulsed Electromagnetic Field (PEMF) Therapy for Post-operative Pain Following Orthopedic Surgery | 2027-02 |
| NCT05344898University of Maryland, BaltimoreSubscap Reverse Shoulder Arthroplasty | 2027-05-15 |
| NCT02600910The University of Texas Medical Branch, GalvestonNatural History of Shoulder Pathology in Manual Wheelchair Users | 2027-06 |
| NCT06501859University of UtahRehabilitation With the Shoulder Pacemaker | 2027-07 |
Add all 7 to your calendar (.ics) → With an account.
Among the 39 studies in Shoulder Injuries with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Retrospective, multi-center, chart review (only to include data that is part of the surgeons' standard practice)
The purpose of this study is to leverage standard of care data to provide further characterization of clinical outcomes following shoulder, hip and knee joint surgeries.
Patients who have undergone a surgical procedure (per indications for use) using the Stryker implants who meet all of the inclusion/exclusion criteria will be screened and enrolled by participating Investigators.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Investigational drug or device
A drug or device being studied in a clinical trial.
It may be new, or already approved and being studied for another use, dose or form. Criteria often leave out people who took part in another study of one within a recent period, commonly 30 days or five half-lives.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients who have undergone a surgical procedure (per product indications for use) using the Stryker implants who meet all of the following criteria will be screened and enrolled by participating Investigators.
Device: Standard of Care Treatment
Subject has undergone joint space repair using one of the study devices and meets eligibility criteria
ASES
Change from baseline
Time frame: 6 months
iHOT-12
Change from baseline
Time frame: 6 months
mHHS
Change from baseline
Time frame: 6 months
Plan to share: No
No publications or documents are linked to this record.
Started Dec 2023 (actual). Primary completion is estimated for Jun 2026, 30 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.